Rat hepatocytes respond to glycogenolytic stimuli acting via phosphoinositide breakdown (e.g. az-adrenergic agonists, vasopressin) by oscillations ofthe free intracellular Ca2+ concentration ([Ca2+] 
INTRODUCTION
For more than 30 years the biguanides metformin (dimethylbiguanide) and phenformin (phenethylbiguanide) have been used as glucose-lowering agents in the treatment of non-insulindependent diabetes mellitus (NIDDM). During the 1970s phenformin was withdrawn in many countries because of an association with lactic acidosis. In spite of intensive research the mechanism of the anti-hyperglycaemic action of biguanides is still a matter of debate (for review see ref. 1) .
In contrast to sulphonylureas, the glucose-lowering effect of biguanides occurs without stimulation of insulin secretion [2] and results mainly from improved basal and insulin-mediated glucose utilization in peripheral tissues such as muscle and adipose tissue [3, 4] . In liver cells high concentrations of metformin ( > 10-3 M) reduce basal and glucagon-stimulated gluconeogenesis in the absence of added insulin [5, 6] . However, therapeutic concentrations of metformin (10-5 M) act synergistically with physiological concentrations of insulin to reduce gluconeogenesis in isolated rat hepatocytes [7, 8] , indicating a requirement of insulin for its therapeutic effect. Despite the fact that in a number of studies an enhancement of insulin binding to its receptor on target cells by metformin is reported [9] [10] [11] [12] [13] , only a poor correlation exists between the effects of metformin on glucose metabolism and the increased insulin binding [14] . This suggests that the potentiation of the insulin action by biguanides occurs distal to insulin receptor binding. In rat hepatocytes metformin did not alter the binding of insulin, but decreased the stimulatory action of glucagon and N,2'-O-dibutyryl-cyclic AMP (db-cAMP) on gluconeogenesis, indicating an effect even at a post-adenylate cyclase step [15] . Moreover metformin increased the insulindependent stimulation of glycogen and lipid synthesis directly without modification of the cell sensitivity to the hormone [16] .
In conclusion, these results indicate that at least part of the anti-hyperglycaemic action of biguanides arises from an alteration of insulin-mediated carbohydrate metabolism (e.g. gluconeogenesis, glycogen synthesis) at a post-receptor level.
It is well established that for a wide variety of cell types the activation of receptors coupled to the breakdown of phosphoinositide (PI) results in oscillations of the free intracellular Ca2+
Abbreviations used: [Ca2+] i, free intracellular Ca2+ concentration; cAMP, cyclic AMP; db-cAMP, N,2'-0-dibutyryl-cAMP; FCS, foetal calf serum; fura-2/AM, fura-2 acetoxymethyl ester; fluo-3/AM, fluo-3 acetoxymethyl ester; NIDDM, non-insulin-dependent diabetes mellitus; PI, phosphoinositide;
[cAMP]cyt, cytosolic cAMP concentration; IP3, inositol 1,4,5-trisphosphate; PKA, cAMP-dependent protein kinase.
* To whom correspondence should be addressed. concentration ([Ca2"],) [17] . In rat hepatocytes [Ca2l] , oscillations occur in response to glycogenolytic agonists (ati-adrenergic agonists, vasopressin) [18, 19] . Besides the elevation of [Ca2+]2 tl;e cell possesses many other routes for intracellular signalling and it may be assumed that the cellular response to extracellular stimuli is the result of a complex cross-talk among the different signalling pathways. In hepatocytes the Ca2+ elevating response induced by agonists acting via PI breakdown has been augmented by agents increasing the cytoplasmic concentration of cAMP [glucagon, forskolin, cyclic AMP (cAMP) analogues] [20] [21] [22] . The elevation of [cAMP] by different agonist alone did not induce [Ca2+]1 oscillations in rat hepatocytes but exerted a positive modulatary effect on phenylephrine-induced [Ca2+]1 spikes [23] . This synergism reflects the common metabolic goal of these agonists [20] . In addition insulin, the physiological counterpart to the gluconeogenetic agonists, has been shown to suppress phenylephrine-induced [Ca2+]1 oscillations [23] .
A prerequisite for sustained [Ca2+]1 oscillations is the entry of Ca2+ from the extracellular space [24] [25] [26] . In hepatocytes Ca2+ mobilizing hormones have been shown to increase the rate at which Mn2+, added to the extracellular medium, quenches the intracellular fluorescence of Ca2+ indicators [27] [28] [29] [30] . Assuming that Mn2+ utilizes the same entry pathways as Ca2+ this quenching could serve as a measure for the agonist-induced Ca2+ inflow into the cytosol [31] .
The aim of this work was to investigate the effects of the antihyperglycaemic agents metformin and phenformin on the Ca2+ signal pathway in rat hepatocytes. For this purpose we have used quantitative fluorescence microscopy to examine the action of biguanides on phenylephrine-induced [Ca2+]1 oscillations. In addition we investigated the effects of biguanides on phenylephrine-induced Ca2+ movements in intact and permeabilized hepatocytes.
MATERIALS AND METHODS
Preparation and freezing of hepatocytes Rat hepatocytes were prepared by EDTA-dissociation according to the method described by Meredith [32] with minor modifications. In brief, male Wistar rats of 200-250 g were anaesthetized by i.p. injection of 50 mg/kg Nembutal. The liver was perfused via the portal vein with Buffer A (in mM): 140 NaCl, 5 KCI, 0.8 MgCl2, 1.6 Na2HPO4, 0.4 KH2PO4, 25 NaHCO3, 2 EDTA, and an incision in the heart was made to allow outflow of the perfusate. The flow rate was adjusted to 50-60 ml/min. The buffer was kept at 37°C and gassed with 95 % 02/5 % CO2. The pH was controlled by carbogen to 7.4. After about 20 min when the liver appeared softened, the perfusion was stopped. The liver was removed and washed in ice-cold Buffer B [Buffer A without EDTA and NaHCO3, but containing 1 mM CaCl2/l0 mM Hepes/1 % BSA (pH 7.4)]. The cells were dissociated by repeated mincing, centrifuged at 30 g, and washed twice in ice-cold buffer B. After adjusting the density to 15 x 106 cells/ml, hepatocytes (about 90% viability as assessed by cell exclusion of trypan blue) were portioned by adding 0.2 ml of this suspension to a freezing vial with 0. [35] . The quench of the fura-2 fluorescence by Mn2+ was measured at the calcium-insensitive excitation wavelength of 360 nm.
Fluorescence measurements In permeabilized hepatocytes
Hepatocytes were loaded with 4 ,M fluo-3 acetoxymethyl ester (fluo-3/AM) in F-12/Hepes culture medium supplemented with 1 % BSA for 20 min at 37 'C. To ensure complete hydrolysis of the ester the cells were incubated for another 10 min at 37 'C in the same buffer without the dye. After this period the incubation buffer was exchanged to a cytosol-like buffer containing 100 mM KCI/20 mM NaCl/5 mM MgCl2/l mM NaH2PO4/25 mM Hepes/5 mM creatine phosphate/5 units/ml creatine kinase (pH 7.4). The cells were permeabilized by the addition of 5 ,uM digitonin. The fluorescence was measured in single cells using the appropriate filter set for fluo-3 (excitation at 480 nm and emission at 520 nm). Inositol 1,4,5-trisphosphate (IP3), heparin and biguanides were added after the cellular fluorescence declined at the same rate prior to permeabilization. Materials BSA, phenylephrine, glucagon, db-cAMP, forskolin and phenformin were purchased from Sigma; collagen R and F-12 culture medium from Serva; Hepes, insulin, MnCl2, heparin and ionomycin from Fluka; fura-2/AM, fura-2 pentapotassium salt and fluo-3/AM from Molecular Probes; EDTA from Boehringer; FCS from Seromed/Biochrom; digitonin from Merck; metformin was a generous gift from Dr. N. Wiernsperger, Lipha (Lyon, France). 
Alteration of the biguanide action by Insulin and glucagon
In a previous study from our laboratory [23] it was demonstrated that phenylephrine-induced [Ca2+]1 oscillations could be nega- (11) 7 (9) 7 (9) oscillations via the cAMP second messenger system [23] . Therefore we investigated whether activation of the cAMP signalling pathway could counteract the inhibitory action of biguanides on phenylephrine- 
DISCUSSION
Concerning the glucose-lowering effects of the biguanides metformin and phenformin thus far there is evidence that they are mainly mediated via an altered glucose metabolism in peripheral tissues [1] . In this study we have investigated whether biguanides can modulate [Ca2+] , oscillations in isolated rat hepatocytes induced by the glycogenolytic agonist phenylephrine. We found that indeed the addition of the biguanides elicited a concentration-dependent reduction of the frequency of the oscillations. In agreement with the documented 100-fold higher therapeutic potency of phenformin as compared with metformin [37] we found the IC50 for phenformin to be two orders of magnitude lower than that of metformin. However, the concentrations required were higher than the therapeutically effective concentrations used in the treatment of NIDDM [8] . There is evidence that biguanides require the presence of insulin for their glucose lowering action in vivo [7, 8, 16] . The significantly increased lowering of the frequency by simultaneous application of insulin and biguanides compared with the effects observed when these agents were added alone, speaks in favour of the enhanced metabolic effects of biguanides by insulin. In rat liver membranes of lean and obese Zucker rats it was shown that metformin decreased the ability of glucagon to stimulate the adenylate cyclase activity [38] To further narrow down the possible site of action of the biguanides, we studied their effects on the phenylephrine-induced Mn2+ quench of the fura-2 fluorescence in intact hepatocytes either loaded with fura-2/AM or the free acid form of the dye. First of all these experiments clearly demonstrated that hepatocytes loaded with fura-2/AM compartimentalize a significant amount of the dye into intracellular organelles. This is further I supported by the fact that in cells loaded with the membraneimpermeable fura-2/pentapotasium salt the addition of Mn2+ caused no increase of the fluorescence ratio measured at 340/380 nm compared with the cells loaded with fura-2/AM. Glennon et al. [30] came to a similar conclusion to explain the failure of the endoplasmic reticulum Ca2+-ATPase inhibitor thapsigargin to induce a Mn2+ influx into hepatocytes loaded with fura-2/AM [28, 29] which was not the case in cells microinjected with fura-2/pentapotassium salt. In AM-loaded cells the monotonic decrease of the ratio and the second quench phase after addition of phenylephrine could then be interpreted as an efflux of Ca2+ out of and an influx of cytosolic Mn2+ into the stores, respectively, due to the opening of the IP3-operated Ca2+ channel. In this context it should be noted that this response could only be observed if we used 10-100 times higher phenylephrine concentrations compared with the concentrations required to induce [Ca2+]1 oscillations. At this hormone concentration hepatocytes are overstimulated, meaning that the IP3 receptor is maximally activated [19] . This indicates that a complete and sustained Ca2+ release from intracellular stores is necessary to induce the observed response.
As a consequence, in hepatocytes loaded with fura-2/AM, the phenylephrine-induced Mn2+ quench and the decrease of the fluorescence ratio may primarily be used as an indicator of the Ca2+ flux across intracellular membranes. Hence, the inhibitory effect of biguanides indicates an alteration of the phenylephrineinduced Ca2+ release from intracellular Ca2+ stores. This is further supported by our findings obtained from experiments with permeabilized hepatocytes loaded with fluo-3/AM. There we observed that the IP3-induced Ca2+ release from intracellular stores could be partially inhibited by prior addition of metformin or phenformin. In contrast to Renard-Rooney et al. [42] we observed a quantal Ca2+ release in single permeabilized and attached hepatocytes. These authors could show that permeabilization by digitonin caused a vesicularization of the endoplasmic reticulum in cells held in suspension, but not in attached cells. This finding could explain why only in unattached cells is the so called 'quantal' Ca2+ release observed. Our results obtained in single, attached hepatocytes might be due to the different isolation protocol of the cells and the use of collagen R instead of polylysine for attachment. Therefore it cannot be excluded that in our preparation a vesicularization of the endoplasmic reticulum might occur after permeabilization.
Our results strongly suggest that the anti-diabetic drugs of the 
